DK2182007T3 - Fremgangsmåde til fremstilling af humant G-CSF - Google Patents

Fremgangsmåde til fremstilling af humant G-CSF

Info

Publication number
DK2182007T3
DK2182007T3 DK10153219.0T DK10153219T DK2182007T3 DK 2182007 T3 DK2182007 T3 DK 2182007T3 DK 10153219 T DK10153219 T DK 10153219T DK 2182007 T3 DK2182007 T3 DK 2182007T3
Authority
DK
Denmark
Prior art keywords
csf
human
preparation
Prior art date
Application number
DK10153219.0T
Other languages
English (en)
Inventor
Sanjeev Kumar Mendiratta
Vibhor Saraswat
Pankaj R Patel
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Application granted granted Critical
Publication of DK2182007T3 publication Critical patent/DK2182007T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/68Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK10153219.0T 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant G-CSF DK2182007T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN309MU2006 2006-03-06
EP07736565.8A EP1994138B1 (en) 2006-03-06 2007-03-05 Process for preparing human g-csf

Publications (1)

Publication Number Publication Date
DK2182007T3 true DK2182007T3 (da) 2014-04-22

Family

ID=38436804

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10153219.0T DK2182007T3 (da) 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant G-CSF
DK07736565.8T DK1994138T3 (da) 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant g-csf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07736565.8T DK1994138T3 (da) 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant g-csf

Country Status (18)

Country Link
US (2) US8021862B2 (da)
EP (2) EP2182007B1 (da)
JP (2) JP4927103B2 (da)
KR (1) KR101176794B1 (da)
CN (2) CN102776261B (da)
AP (2) AP2647A (da)
AU (1) AU2007224331B2 (da)
BR (1) BRPI0707078A2 (da)
CA (1) CA2642654C (da)
DK (2) DK2182007T3 (da)
EA (2) EA022782B1 (da)
HK (2) HK1127617A1 (da)
MX (1) MX2008011407A (da)
MY (1) MY149168A (da)
NZ (2) NZ596111A (da)
PL (2) PL2182007T3 (da)
WO (1) WO2007102174A2 (da)
ZA (1) ZA200806978B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009066320A2 (en) * 2007-09-21 2009-05-28 Cadila Healthcare Limited Fusion protein systems suitable for high expression of peptides
WO2011086447A2 (en) 2010-01-12 2011-07-21 Lupin Limited Fermentation process for the preparation of recombinant heterologous proteins
CN108103243A (zh) * 2018-01-04 2018-06-01 哈尔滨瀚邦医疗科技有限公司 一种猪乙脑病毒遗传稳定性的检测方法及应用
CN114350588B (zh) * 2021-12-31 2024-03-15 山东新时代药业有限公司 一种rhG-CSF的发酵培养基及其发酵方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
CA2591235C (en) * 2004-12-20 2014-03-11 Cadila Healthcare Limited Process for preparing high levels of interferon beta

Also Published As

Publication number Publication date
AP2008004592A0 (en) 2008-08-31
EA015498B1 (ru) 2011-08-30
CN102776261A (zh) 2012-11-14
CA2642654C (en) 2014-04-22
EP1994138A2 (en) 2008-11-26
EP2182007B1 (en) 2014-03-05
CA2642654A1 (en) 2007-09-13
EA200870320A1 (ru) 2009-02-27
JP4927103B2 (ja) 2012-05-09
US8492120B2 (en) 2013-07-23
US20110070611A1 (en) 2011-03-24
CN101410410A (zh) 2009-04-15
AU2007224331B2 (en) 2011-05-26
WO2007102174A3 (en) 2008-01-03
PL2182007T3 (pl) 2014-06-30
AP2012006440A0 (en) 2012-08-31
ZA200806978B (en) 2009-05-27
AP2647A (en) 2013-04-17
US8021862B2 (en) 2011-09-20
HK1127617A1 (en) 2009-10-02
CN101410410B (zh) 2013-06-12
KR20080104011A (ko) 2008-11-28
JP2009528836A (ja) 2009-08-13
CN102776261B (zh) 2014-09-24
US20090305354A1 (en) 2009-12-10
HK1176645A1 (en) 2013-08-02
KR101176794B1 (ko) 2012-08-24
EP2182007A1 (en) 2010-05-05
WO2007102174A2 (en) 2007-09-13
EP1994138B1 (en) 2014-04-30
AP3142A (en) 2015-02-28
BRPI0707078A2 (pt) 2011-04-19
EA201100718A1 (ru) 2012-02-28
NZ571337A (en) 2011-12-22
PL1994138T3 (pl) 2014-08-29
EA022782B1 (ru) 2016-03-31
DK1994138T3 (da) 2014-05-12
NZ596111A (en) 2012-12-21
JP5460660B2 (ja) 2014-04-02
JP2011229541A (ja) 2011-11-17
MY149168A (en) 2013-07-31
AU2007224331A1 (en) 2007-09-13
MX2008011407A (es) 2008-09-24

Similar Documents

Publication Publication Date Title
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK2231565T3 (da) Fremgangsmåder til fremstilling af clorerede carbonhydrider
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK2296651T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater til behandling af bakterielle intestinale sygdomme
DK2285416T3 (da) Konjugat til behandlingen af mesotheliom
DK2109449T3 (da) Lægemiddel til behandling af endometriose